Role of toll-like receptor 4 and caspase-3, -8, and -9 in lipopolysaccharide-induced delay of apoptosis in equine neutrophils.

The research study investigates how lipopolysaccharide (LPS), a molecule from E. coli bacteria, affects the apoptosis (programmed cell death) of equine (horse) neutrophils (a type of white blood cell) in a laboratory setting. The results indicate that exposure to LPS delays apoptosis in these cells, which could contribute to inflammation and illness in horses.

Methodology

• The researchers sourced blood samples from 40 adult horses.
• The neutrophils were isolated from these samples and then cultured either with or without LPS from Escherichia coli O55:B5 for a period of 12 or 24 hours.
• Apoptosis of the neutrophils was assessed using cytologic examination, staining quantified with flow cytometry, and measurement of the activities of caspases (proteins involved in apoptosis).
• The effect of LPS was investigated with different dosages and its interaction with toll-like receptor (TLR) 4, an immune system receptor.

Results

• The treatment with LPS resulted in significant delay in apoptosis after 12 and 24 hours of incubation.
• There was a noted correlation between increased LPS doses and decreased apoptosis after 24 hours.
• Caspase-9 activity decreased significantly in LPS-treated neutrophils after incubation for 12 hours. However, caspase-3 and -8 activity did not significantly change.
• The use of a TLR4 inhibitor or inducers of intrinsic and extrinsic apoptosis was able to prevent the LPS-delayed apoptosis.

Conclusions and Clinical Relevance

• The researchers concluded that LPS treatment delays the apoptosis of equine neutrophils for up to 24 hours in a dose-dependent manner, by altering the intrinsic pathway of apoptosis. This process is dependent on TLR4 signaling.
• The study suggests that the increased lifespan of neutrophils, due to delayed apoptosis, may contribute to systemic inflammatory response syndrome in endotoxemic horses. This could help develop targeted treatment strategies for related conditions in horses in the future.